MAGDA VALDES: Open Payments
NPI 1285001859 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 25 payments from 12 companies in 2025. Trend: 2023 $1,880 · 2024 $812 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $200 |
| Lilly USA, LLC | 6 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $119 |
| Ardelyx, Inc. | 1 | $110 |
| Vifor Pharma, Inc. | 1 | $91 |
| Daiichi Sankyo Inc. | 3 | $80 |
| PFIZER INC. | 3 | $69 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: Enhertu, VERZENIO, LYNOZYFIC, ELAHERE, XPHOZAH 30 MG, Veltassa, IBRANCE, DARZALEX.
Industry payments across FL — which companies pay providers there.
